Prestige Consumer Healthcare
PBH
#3924
Rank
HK$24.77 B
Marketcap
HK$503.34
Share price
-1.54%
Change (1 day)
-14.25%
Change (1 year)

EPS for Prestige Consumer Healthcare (PBH)

EPS in 2025 (TTM): HK$31.63

According to Prestige Consumer Healthcare's latest financial reports the company's current EPS (TTM) is HK$31.72. In 2024 the company made an earnings per share (EPS) of HK$33.59 an increase over its 2023 EPS that were of -HK$12.58.

EPS history for Prestige Consumer Healthcare from 2011 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$31.63-5.83%
2024HK$33.59-367.08%
2023-HK$12.58-138.33%
2022HK$32.8111.7%
2021HK$29.3713.6%
2020HK$25.86-651.67%
2019-HK$4.69-148.78%
2018HK$9.61-83.29%
2017HK$57.50437.23%
2016HK$10.70-34.13%
2015HK$16.2552.94%
2014HK$10.62-8.11%
2013HK$11.56
2011HK$6.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.55 157.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Procter & Gamble
PG
HK$54.92 73.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.50 81.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$13.44-57.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
HK$62.94 98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Clorox
CLX
HK$50.08 57.88%๐Ÿ‡บ๐Ÿ‡ธ USA
CVS Health
CVS
HK$3.12-90.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$28.09-11.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Rite Aid
RAD
-HK$231.40-829.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Taro Pharmaceutical
TARO
HK$9.53-69.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel